Pharmaceutical Technology

FEBRUARY 3, 2023

This is really what has been very challenging for upscaling viral vector production and what leads some companies that have in-licensed projects with a huge amount of viral vector to slightly panic about future production,” she says. Cytiva and the Drop logo are trademarks of Life Sciences IP Holdings Corp. Biores Open Access.

Genome 244

Genome Genomics Medicine Gene Therapy 244

Drug Discovery World

APRIL 25, 2024

The market for cell line development is currently rising due to an increased focus by the life sciences sector on biopharmaceuticals and targeted therapies. He has worked in life sciences and pharmaceutical B2B publishing for seven years and was previously Editor of European Pharmaceutical Manufacturer.

Development 59

Development Protein In-Vivo Life Science 59

XTalks

JULY 25, 2023

While there is no evidence of person-to-person transmission, anthrax skin lesions may be contagious through direct contact or contaminated objects. The bacteria usually enter the body through wounds, but infection can also occur through contaminated meat or inhalation of spores. Overall, 66.3 on Day 64 in the study.

FDA Approval 98

FDA Approval Vaccination Vaccine Antibody 98

XTalks

JANUARY 4, 2023

There were multiple preclinical studies and eight clinical studies that were included in MediWound’s Biologics License Application (BLA) for NexoBrid. Wibbenmeyer, MD, clinical professor of Surgery-Acute Care Surgery, Iowa City, IA, and past president of the American Burn Association, in MediWound’s press release. Clinical Trials of NexoBrid.

FDA Approval 98

FDA Approval Clinical Trials Clinical Trials Contamination 98

XTalks

MAY 20, 2022

She said it is also spread through open sores, contact with bodily fluids or by touching contaminated clothes or bedding. In the US, JYNNEOS (also known as Imvamune or Imvanex) is a vaccine that is licensed to prevent both monkeypox and smallpox. Treatments. Outbreaks Outside Africa.

Vaccination 98

Vaccination Vaccine Contamination Licensing 98

XTalks

MAY 29, 2024

In its acquisitions, J&J also acquired antibody-drug conjugate (ADC) developer Ambryx and cardiac med tech Laminar along with more than 50 smaller, early-stage licensing deals and partnerships. Issues of nitrosamine contamination during manufacturing have also plagued Januvia since 2022, compounding the decline in sales.

Pharma Companies 52

Pharma Companies Sales FDA Approval Vaccination 52

The Pharma Data

NOVEMBER 15, 2020

She chairs the board of directors of Sellas Life Sciences, a publicly traded biotechnology company, chairs its nominations & governance committee, and is a member of its audit, compensation and finance committees. and international leadership positions, including Staff Vice President and Associate General Counsel.

Clinical Trials 40

Clinical Trials Clinical Trials Production Trials 40